• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床相关分化型甲状腺癌的初始归因成本和经济负担:医疗服务提供者视角

Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.

作者信息

Lang B H-H, Wong C K H, Chan C T Y

机构信息

Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region.

Department of Family Medicine and Primary Care, University of Hong Kong, 3/F Ap Lei Chau Clinic, 161 Main Street, Ap Lei Chau, Hong Kong Special Administrative Region.

出版信息

Eur J Surg Oncol. 2015 Jun;41(6):758-65. doi: 10.1016/j.ejso.2015.01.019. Epub 2015 Jan 31.

DOI:10.1016/j.ejso.2015.01.019
PMID:25680952
Abstract

BACKGROUND

Rapid rise in differentiated thyroid cancer (DTC) may impose a heavy economic burden on future healthcare. We aimed to calculate the average first-year monetary cost/patient for DTC and estimate the projected cost burden on our local healthcare system.

METHODS

Medical records of 270 clinically-relevant DTC patients were reviewed to calculate the amount of services utilized during the first-year. Only direct costs were included with estimates derived from government gazette. Cancer incidences were derived from the territory-wide cancer registry. Total annual cost equaled to the incidence multiplied by the cost/patient.

RESULTS

The average first-year cost of DTC was USD11,560/patient. Initial surgery accounted for 66.9% of total cost. Male and female annual percentage increases for DTC were 4.86% and 4.28%, respectively. Female DTC is projected to surpass rectal cancer in 2019 (20.4/100,000 vs. 20.0/100,000) and colon cancer (47.2/100,000 vs. 46.8/100,000) in 2039. However, the projected incidence of DTC in 2026 would still be about one fourth that of CRC (19.5/100,000 vs. 83.2/100,000).

CONCLUSIONS

The average first-year monetary cost of DTC care was relatively low. Initial surgery accounted for most of the cost. Despite a rapid incidence rise, the projected first-year cost for DTC is unlikely to impose substantial economic burden on our local future healthcare system.

摘要

背景

分化型甲状腺癌(DTC)的快速增长可能给未来的医疗保健带来沉重的经济负担。我们旨在计算DTC患者第一年的平均货币成本,并估计本地医疗系统的预计成本负担。

方法

回顾了270例具有临床相关性的DTC患者的病历,以计算第一年使用的服务量。仅包括直接成本,估算值来自政府公告。癌症发病率来自全地区癌症登记处。年度总成本等于发病率乘以每位患者的成本。

结果

DTC患者第一年的平均成本为每人11,560美元。初次手术占总成本的66.9%。DTC男性和女性的年增长率分别为4.86%和4.28%。预计女性DTC在2019年将超过直肠癌(20.4/10万对20.0/10万),并在2039年超过结肠癌(47.2/10万对46.8/10万)。然而,2026年DTC的预计发病率仍将约为结直肠癌的四分之一(19.5/10万对83.2/10万)。

结论

DTC护理第一年的平均货币成本相对较低。初次手术占成本的大部分。尽管发病率迅速上升,但DTC预计的第一年成本不太可能给我们当地未来的医疗系统带来重大经济负担。

相似文献

1
Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.临床相关分化型甲状腺癌的初始归因成本和经济负担:医疗服务提供者视角
Eur J Surg Oncol. 2015 Jun;41(6):758-65. doi: 10.1016/j.ejso.2015.01.019. Epub 2015 Jan 31.
2
Differentiated thyroid cancer: millions spent with no tangible gain?分化型甲状腺癌:花费数百万,却毫无成效?
Endocr Relat Cancer. 2018 Jan;25(1):51-57. doi: 10.1530/ERC-17-0397. Epub 2017 Oct 17.
3
The clinical and economic burden of a sustained increase in thyroid cancer incidence.甲状腺癌发病率持续增加的临床和经济负担。
Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1252-9. doi: 10.1158/1055-9965.EPI-13-0242. Epub 2013 May 15.
4
High default rate in thyroid cancer management in Ibadan, Nigeria: a need for health insurance.尼日利亚伊巴丹甲状腺癌治疗中的高违约率:医疗保险的必要性。
Afr J Med Med Sci. 2012 Dec;41 Suppl:105-9.
5
Annual financial impact of well-differentiated thyroid cancer care in the United States.美国分化型甲状腺癌治疗的年度经济影响。
Cancer. 2014 May 1;120(9):1345-52. doi: 10.1002/cncr.28562. Epub 2014 Jan 30.
6
Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.在瑞典的一个县中分化型甲状腺癌——长期结果和生活质量。
Acta Oncol. 2010 May;49(4):454-9. doi: 10.3109/02841860903544600.
7
Cost-effective management of low-risk papillary thyroid carcinoma.低风险甲状腺乳头状癌的经济高效管理
Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1245-53. doi: 10.1001/archotol.133.12.1245.
8
Attributable costs of differentiated thyroid cancer in the elderly Medicare population.老年医疗保险人群中分化型甲状腺癌的归因成本。
Surgery. 2013 Dec;154(6):1363-9; discussion 1369-70. doi: 10.1016/j.surg.2013.06.042. Epub 2013 Aug 22.
9
The economic burden of major adult visual disorders in the United States.美国主要成人视觉障碍的经济负担。
Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754.
10
Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.常规喉镜检查在分化型甲状腺癌手术治疗中的成本效益。
Ann Surg Oncol. 2018 Apr;25(4):949-956. doi: 10.1245/s10434-018-6356-2. Epub 2018 Feb 7.

引用本文的文献

1
The Unappreciated Value of a Cheap, 'Good Enough' Method of Detecting Thyroid Cancer.一种廉价且“足够好”的甲状腺癌检测方法的未被重视的价值。
J Clin Med. 2024 Nov 30;13(23):7290. doi: 10.3390/jcm13237290.
2
Exploring temporal trends and influencing factors for thyroid cancer in Guangzhou, China: 2004-2018.探讨中国广州甲状腺癌的时间趋势和影响因素:2004-2018 年。
Endocrine. 2024 May;84(2):509-523. doi: 10.1007/s12020-023-03578-2. Epub 2023 Nov 7.
3
Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis.
中国晚期放射性碘难治性分化型甲状腺癌患者应用血管内皮生长因子受体抑制剂:一项网络荟萃分析和成本效益分析。
Front Endocrinol (Lausanne). 2022 Jul 14;13:909333. doi: 10.3389/fendo.2022.909333. eCollection 2022.
4
The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research.经济评价的概念及其在甲状腺癌研究中的应用。
Endocrinol Metab (Seoul). 2021 Aug;36(4):725-736. doi: 10.3803/EnM.2021.1164. Epub 2021 Aug 27.
5
Differentiated Thyroid Cancer: A Health Economic Review.分化型甲状腺癌:健康经济学综述。
Cancers (Basel). 2021 May 7;13(9):2253. doi: 10.3390/cancers13092253.
6
Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis.美国社区居住的甲状腺癌成年患者的医疗保健支出:一项倾向评分匹配分析。
Heliyon. 2019 Jun 24;5(6):e01995. doi: 10.1016/j.heliyon.2019.e01995. eCollection 2019 Jun.
7
Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases.中文患者良性甲状腺疾病中 ThyPRO 短式(ThyPRO-39)的测量特性。
Qual Life Res. 2018 Aug;27(8):2177-2187. doi: 10.1007/s11136-018-1857-9. Epub 2018 Apr 18.